PBE Holdings Information

PBE is an equity ETF with a total of 33 individual holdings. The top holdings are Incyte stock at 5.11%, Biogen at 5.07%, Vertex Pharmaceuticals at 5.01%, Gilead Sciences at 4.84%, and Royalty Pharma at 4.78%.

Total Holdings

Top 10 Percentage

46.55%

Asset Class

Equity

ETF Category

n/a

Assets

229.72M

PE Ratio

17.77

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	INCY	Incyte Corporation	5.11%	127,154
2	BIIB	Biogen Inc.	5.07%	78,120
3	VRTX	Vertex Pharmaceuticals Incorporated	5.01%	27,597
4	GILD	Gilead Sciences, Inc.	4.84%	93,081
5	RPRX	Royalty Pharma plc	4.78%	296,857
6	ILMN	Illumina, Inc.	4.69%	108,181
7	AMGN	Amgen Inc.	4.64%	36,883
8	REGN	Regeneron Pharmaceuticals, Inc.	4.59%	18,176
9	IONS	Ionis Pharmaceuticals, Inc.	4.35%	138,155
10	EXAS	Exact Sciences Corporation	3.46%	126,347
11	UTHR	United Therapeutics Corporation	3.43%	18,842
12	PTCT	PTC Therapeutics, Inc.	3.41%	117,792
13	MNKD	MannKind Corporation	3.35%	1,431,429
14	SRPT	Sarepta Therapeutics, Inc.	3.24%	319,055
15	VCYT	Veracyte, Inc.	3.11%	200,411
16	TECH	Bio-Techne Corporation	2.85%	102,586
17	NBIX	Neurocrine Biosciences, Inc.	2.74%	42,575
18	CPRX	Catalyst Pharmaceuticals, Inc.	2.70%	292,174
19	EXEL	Exelixis, Inc.	2.62%	151,956
20	AKBA	Akebia Therapeutics, Inc.	2.58%	1,885,407
21	MDGL	Madrigal Pharmaceuticals, Inc.	2.58%	13,712
22	DVAX	Dynavax Technologies Corporation	2.53%	558,037
23	VCEL	Vericel Corporation	2.52%	159,832
24	QGEN	Qiagen N.V.	2.49%	119,237
25	BMRN	BioMarin Pharmaceutical Inc.	2.31%	101,408

Showing 25 of 33 holdings

Subscribe to see the full list

Activate Now

As of Oct 27, 2025